|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Metro Drug Inc
Main Activities: Health and Personal Care Stores
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Metro Drug Inc Headquarters Compound, Mañalac Avenue, Bagumbayan, Taguig City; Taguig; National Capital Region; 1631 |
Status: Non-Listed Legal Form: Limited Liability Company Operational Status: Operational CIBI: A199720671 Financial Auditors: ISLA LIPANA AND COMPANY (2011) Tel: (02) 8372121 |
|
Company Description |
| Distributor of pharmaceutical and veterinary products, personal care and other related products.The company has exclusive distributorship agreements with various principals commencing and terminating on various dates. The agreements are renewable upon such terms and conditions as may be agreed upon by both parties.Customers include major hospitals and pharmacies nationwide including Mercury Drug, Watson’s, South Star Drug, Manson Drug among others.Supplies are purchased from local suppliers. |
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2010, total net operating revenues decreased with -2.19%, from PHP 14,250,313.9 thousands to PHP 13,938,889.19 thousands. Operating result decreased from PHP 512,410.83 thousands to PHP 463,296.1 thousands which means -9.59% change. The results of the period decreased -8.97% reaching PHP 327,640.48 thousands at the end of the period against PHP 359,923.38 thousands last year. Return on equity (Net income/Total equity) went from 47.37% to 45.04%, the Return On Asset (Net income / Total Asset) went from 8.18% to 7.57% and the Net Profit Margin (Net Income/Net Sales) went from 2.53% to 2.35% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 494.85% compared to 479.10% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.04 to 1.03 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2010 Y (non-cons) |
2009 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| CIBI Top 25000 Private Company Financials | CIBI Top 25000 Private Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
4,327,112 |
4,399,992 |
| ||
Current Assets |
X,XXX,XXX |
X,XXX,XXX |
| ||
Total Liabilities |
X,XXX,XXX |
X,XXX,XXX |
| ||
Shareholders Equity |
XXX,XXX |
XXX,XXX |
| ||
Current Liabilities |
X,XXX,XXX |
X,XXX,XXX |
| ||
| * All the accounts are in PHP. | ||
Income Statement
| ||
Total Operating Revenue |
XX,XXX,XXX |
XX,XXX,XXX |
| ||
Operational Profit (Loss) |
XXX,XXX |
XXX,XXX |
| ||
Net Profit (Loss) |
XXX,XXX |
XXX,XXX |
| ||
| * All the accounts are in PHP. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
XX.XX% |
XX.XX% |
| ||
Annualised Return on Assets (ROA) |
X.XX% |
X.XX% |
| ||
Return on Equity (ROE) |
XXX.XX% |
XXX.XX% |
| ||
Annualised Return on Equity (ROE) |
XXX.XX% |
XXX.XX% |
| ||
Return on Sales (ROS) |
X.XX% |
X.XX% |
| ||
Gross Profit Margin |
X.XX% |
X.XX% |
| Efficiency Ratios | ||
| ||
Inventory Turnover |
XX.XXx |
XX.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX,XXX |
XXX,XXX |
| ||
EBITDA |
XXX,XXX |
XXX,XXX |
| ||
Bookvalue (BV) |
XXX,XXX |
XXX,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX.XX% |
XXX.XX% |
| ||
Quick ratio |
XX.XX% |
XX.XX% |
| ||
Doom's day ratio |
XX.XX% |
XX.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX.XX% |
XXX.X% |
| ||
Interest Coverage Ratio |
X% |
XX,XXX.XX% |
| ||
Debt to equity |
X,XXX.XX% |
X,XXX.X% |
| ||
Debt to total assets |
XX.XX% |
XX.XX% |
| Trend Ratios | ||
| ||
Revenue Trend |
XX.X% |
XXX.XX% |
| ||
Net Income Trend |
XX.XX% |
XXX.XX% |
| ||
 |